Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Estramustine phosphate sodium (Ro 21-8837/001) is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 59.00 | |
50 mg | In stock | $ 98.00 | |
100 mg | In stock | $ 139.00 |
Description | Estramustine phosphate sodium (Ro 21-8837/001) is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle. |
Synonyms | Ro 21-8837/001, Estramustine phosphate disodium |
Molecular Weight | 564.35 |
Formula | C23H30Cl2NNa2O6P |
CAS No. | 52205-73-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 62.5 mg/mL (110.75 mM), Sonication is recommended.
DMSO: 10 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Estramustine phosphate sodium 52205-73-9 Apoptosis Cytoskeletal Signaling Microtubule Associated microtubule (MT) cytoskeleton prostate cancer Antimicrotubule Ro 21-8837/001 Estramustine phosphate disodium Estramustine Phosphate inhibit Inhibitor transforming growth factor-β Estramustine phosphate MiR-31 antimitotic antitumour Microtubule/Tubulin inhibitor